Jun 9-10, BIW CN2021 biomedical conference was successfully held in Suzhou. this event was organized in the theme is “cooperation, integration and innovation”. Through the form of "exhibition in the conference", the organizer invited thousand of leaders of the innovation ecosystem to discuss the development strategy for the next decade. The conference focused on new therapies and next-generation biotechnology, explored innovative achievements with tech transfer, and shared successful case studies. The conference gathered 1000 + guests, 100 + KOLs, 350 + one-on-one meetings and 40 + cutting-edge technology exhibitors.
Dr. Wu Hui, Founder of iCCAMT, was invited to attend the panel discussion, together with other KOLs, held a heated discussion on several hot issues on the subject of 'how cell/gene therapy can be commercialized'. Dr. Wu Hui said that cell and gene therapy is one of the most emerging fields in the world. Driven by various factors such as market, capital, policy and other factors, China's cell therapy industry is developing rapidly, local enterprises are racing against the clock to carry out clinical research. It is a dynamic market with rapid development in both technology and process, to achieve rapid growth, enterprises need to pay attention to many challenges in the process of commercialization.